Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

FDA panel backs J&J’s new-class antidepressant

FDA panel backs J&J’s new-class antidepressant Allergan also has a contender in phase 3 trials, rapastinel, that could be free of the dependency risk of J&J’s drug but is roughly a year behind in development.

Editas CEO exits the CRISPR firm ahead of first clinical trial

Editas CEO exits the CRISPR firm ahead of first clinical trial It’s due to be tested in 10-20 patients with LCA in the US and Europe later this year, with the assistance of partner Allergan which paid $15m for rights

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan (its US marketing partner) have also just secured a vital Linzess patent settlement with generic challenger Mylan.

NICE rejects Novartis migraine treatment Aimovig

NICE rejects Novartis migraine treatment Aimovig NICE says Novartis has failed to supply data on relevant comparators and outcomes, such as how Aimovig compares to Allergan's Botox, which it approved for migraine prevention in 2016.

Shire bags US approval for constipation drug Motegrity

Shire bags US approval for constipation drug Motegrity Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like ... Linzess (linaclotide) – which brought in almost $575m in

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics